Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.

J. F. Correia-Silva,O. Bruna-Romero,R. G. Resende,L. P. M. Miranda,F. Oliveira,F. Costa,S. G. Xavier,S. P. Figueiredo-Neves,H. C. Almeida,H. Bittencourt,R. Gomez

DOI: https://doi.org/10.1111/j.1601-0825.2009.01637.x

2010-03-01

Oral Diseases

Abstract:OBJECTIVE The purpose of this study was to investigate the use of saliva for the identification of human cytomegalovirus (HCMV) in allogeneic hematopoietic stem cell transplant patients by real time PCR compared with blood. MATERIALS AND METHODS Saliva and blood samples were sampled weekly in 30 allogeneic hematopoietic stem cell transplant patients until 100 days after transplant. Total genomic DNA, extracted from saliva and whole-blood samples, was used for HCMV real time PCR. Nonparametric tests were performed, and P value <or=0.05 was considered statistically significant. RESULTS Human cytomegalovirus DNA load in saliva showed a high correlation with viral DNA in the blood (R = 0.858; P < 0.0001). Blood DNA levels also correlated with HCMV antigenemia (R = 0.773; P < 0.0001). The HCMV levels in saliva (P = 0.015) and blood (P = 0.008) showed higher levels at the beginning of antiviral treatment, with clear reduction after this period. Saliva showed earlier HCMV reactivation than blood detected by real time PCR and antigenemia assay in 11 out of 22 subjects. CONCLUSIONS This study shows that the real time PCR test could be useful to identify HCMV DNA in saliva and to monitor patients at risk of cytomegalovirus disease after allogeneic hematopoietic stem cell transplant. However, further studies are necessary to confirm this data.